Capra Biosciences
Biology-powered production of renewable chemicals.
- Headquarters
- Sterling, Virginia
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- caprabiosciences.com
- Total Funding
- $12.3M
- Last Round
- $7.5M GrantJul 2024
About
Capra Biosciences uses patented bioreactor technology to produce high-performance, renewable bio-based chemicals affordably and sustainably. The company is revolutionizing chemical production by transforming byproducts into valuable materials, with applications in pharmaceutical ingredient manufacturing and industrial chemicals. Capra has received a $7.5M DARPA project agreement to scale its platform.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account